Advanced search

Founder of Exeter Resource Corp., Yale Ronald Simpson is a businessperson who has been the head of 15 different companies and holds the position of Chairman for Rugby Mining Ltd., Chairman at Adamera Minerals Corp., President & Director at Britannia Beach Historical Society, President at Canaust Resource Consultants Ltd. and Chief Executive Officer of Chevron Australia Exploration 1 Pty Ltd. Mr. Simpson is also on the board of BC Museum of Mining, Estelar Resources Ltd. and C3 Metals Inc. In his past career he occupied the position of Chairman at Argosy Minerals Ltd. and Chief Executive Officer of Argosy Mining Corp. (a subsidiary of Argosy Minerals Ltd.), Chief Executive Officer of Chevron Corp., Co-Chairman for Exeter Resource Corp., Chairman for Christopher James Gold Corp., Co-Chairman for Extorre Gold Mines Ltd., Chairman at Core Gold, Inc., Chief Executive Officer for Pennzoil Co., Chief Executive Officer for Australmin Holdings Ltd. and Chief Executive Officer at Brazilian Diamonds Ltd. Mr. Simpson received an undergraduate degree from the University of British Columbia.

Shelley Simpson is currently the President & Director at J.B.
Hunt Transport Services, Inc. She started this position in 2024.
Prior to her current role, she obtained an undergraduate degree from the University of Arkansas System in 1994.

Currently, C. Jeffrey Simpson occupies the position of Chairman, President & Chief Executive Officer of Viewlocity, Inc. He previously held the position of Chairman & Chief Executive Officer for Guidewire Software, Inc., Senior Vice President at Oracle Corp., Principal at HBOC Plc, Principal at International Business Machines Corp. and Executive Vice President for i2 Technologies, Inc.

Presently, Jason Simpson holds the position of Vice President-Engineering for Choice Hotels International, Inc. Mr. Simpson received an undergraduate degree and an MBA from Arizona State University.

Stuart Campbell Simpson is currently the Chief Executive Officer at Vertical Aerospace Ltd.
and the Chief Financial Officer & Director at Avast Software sro.
He is also a Director at RMGLS Holdco Ltd.
Previously, he served as the Chief Executive Officer & Executive Director at International Distributions Services Plc and as a Director at Royal Mail Group Ltd.
He was also the Chief Financial Officer & Executive Director at Avast Ltd.
Additionally, he held a position as the Deputy Group Chief Financial Officer at Teledyne e2v Ltd.
Mr. Simpson completed his undergraduate degree at Newcastle University.

Mr. Michael J.
Simpson is President, Chief Executive Officer & Director at Caradigm USA LLC.
He is on the Board of Directors at Caradigm USA LLC.
Mr. Simpson was previously employed as Senior Vice President-Technology Solutions by QuadraMed Corp.
and Chief Technology Officer & Senior Vice President by McKesson Corp.
He received his undergraduate degree from the University of Phoenix.

Presently, Todd E. Simpson is Chairman for Neoleukin Therapeutics, Inc. and Chief Financial Officer for Seagen Inc. Mr. Simpson is also on the board of Cascadian Therapeutics, Inc. and Washington Biotechnology & Biomedical Association. In his past career he held the position of CFO, VP-Finance & Administration at Vericel Corp., Treasurer at Integra LifeSciences Holdings Corp. and Chief Financial Officer & Vice President of Telios Pharmaceuticals, Inc. (a subsidiary of Integra LifeSciences Holdings Corp.), CFO & VP-Finance & Administration at AmpliPhi Biosciences Corp. and Principal at Ernst & Young LLP. He received an undergraduate degree from Oregon State University.

Sir James Young Simpson, 1st Baronet (7 June 1811 – 6 May 1870) was a Scottish obstetrician and an important figure in the history of medicine. Simpson discovered the anaesthetic properties of chloroform and successfully introduced it for general medical use.

Career

Simpson completed his final examination at the age of 18 but, as he was so young, had to wait two years before he got his license to practice medicine. In 1838 he designed the Air Tractor, the earliest known vacuum extractor to assist childbirth but the method did not become popular until the invention of the ventouse over a century later. At the age of 28 he was appointed to the Chair of Medicine and Midwifery at the University of Edinburgh. He improved the design of obstetric forceps that to this day are known in obstetric circles as "Simpson's Forceps" and, like Semmelweis, fought against the contagion of puerperal sepsis. His most noted contribution was the introduction of anaesthesia to childbirth.

[of James Young Simpson, Queen Street, Edinburgh.jpg|thumb|52 Queen Street]

Simpson's intellectual interests ranged from archaeology to an almost taboo subject at the time: hermaphroditism. He was a very early advocate of the use of midwives in the hospital environment. Many prominent women also consulted him for their gynaecological problems. Simpson wrote Homœopathy, it's Tenets and Tendencies refuting the ideas put forward by Hahnemann.

It was his achievements and wide ranging interests that led to his town house at 52 Queen Street, Edinburgh being a gathering point for many members of society, especially intellectuals. His impish sense of humour got the better of him on at least one of these occasions when he seated a Southern US slave owner next to a freed slave at the dinner table. Since this town house was fairly busy at times, Simpson preferred to keep his wife and children at their country house near Bathgate. In religion Simpson was a devout adherent of the Free Church of Scotland, but he refused to sign the Westminster Confession of Faith, because of what he believed to be its literal interpretation of the book of Genesis.

Simpson was a close friend of Sir David Brewster, and was present at his deathbed.

Source @ Wikipedia

Kristen Simpson has worked as a Vice President-Legal & Compliance at Inter Pipeline Ltd.
since 2010.

Presently, Barry N. Simpson holds the position of Chief Platform Services Officer & Senior VP at The Coca-Cola Co. He previously held the position of Vice President-Global Information Technology at Colgate-Palmolive Co. and Group Chief Information Officer at Coca-Cola Amatil Ltd. He received an undergraduate degree from The University of Sydney.

Colin L.
Simpson is currently the Chief Financial Officer at Manulife Financial Corp.
He previously worked as the Director-Investor Relations at Aviva Plc from 2013 to 2015, a Research Analyst at Goldman Sachs International from 2008 to 2013, and as the Chief Financial Officer at Aviva Plc in 2022.
He also worked as a Research Analyst at Bear Stearns International Ltd.
and as the Chief Financial Officer at Aviva Canada, Inc. Mr. Simpson completed his undergraduate degree at the University of Cape Town.

Kenneth P.
Yale is the founder of Advanced Health Solutions.
He is currently an Independent Director at BIOLASE, Inc. His former jobs include Chief Executive Officer at Health Solutions Network LLC, Medical Director at Aetna, Inc., Executive Director-White House at Domestic Policy Council, Vice President-Government Programs at Matria Healthcare, Inc., Senior Vice President & General Counsel at Kaplan EduNeering, Inc., Chief of Staff at Office of Science & Technology Policy, Chief Clinical Officer at Delta Dental Insurance Co., Vice President at The Jefferson Group Ltd., and Vice President at CoRsolutions, Inc. He received his undergraduate degree from Creighton University, his doctorate from the University of Maryland, and another undergraduate degree from Georgetown University.

Yale Block has held positions as a Trustee at Englewood Hospital & Medical Center, Inc. and as President at Basic Adhesives LLC.

Yale Abrams is currently the Director at Sonoma County Family Young Men's Christian Association.
Prior to this, he was the Director at Blood Bank of The Redwoods.

Prior to joining First Republic in 2008, Mr. Kofman was a Managing Director and Portfolio Manager at Charles Schwab Investment Management in San Francisco, where he was responsible for its proprietary managed accounts program and for implementing its mutual fund wrap offer.
In addition, he helped in the portfolio design of several mutual funds and was a member of Schwab's Investment Strategy Council, which determines the asset allocation and sector guidelines for retail investors.
He has a strong background in portfolio management, investment product development and systems infrastructure.
He began his career in 1992 and his experience includes positions as Assistant Vice President in the Wealth Management group at California Bank & Trust and Vice President & Trust Officer at Greater Bay Bank.
Mr. Kofman holds a B.A.
from Lewis & Clark College and a J.D.
from the University of San Francisco School of Law.

Jean-Francois Yale is currently a Professor at McGill University.
Previously, he was the Chairman-Clinical & Scientific Section at Diabetes Canada from 1992 to 1994 and an Independent Director at Diagnos, Inc. from 2019 to 2020.

Jason Yale worked as an Associate at Colliers International Property Consultants, Inc. from 2014 to 2018.

Dr. Yale I.
Jen is a Managing Director & Senior Biotechnology Analyst at Laidlaw & Co. Prior to joining Laidlaw & Co in September 2013, Dr. Jen was Senior Research Analyst at ROTH Capital Partners.
He was alo a Senior Equity Analyst at Maxim Group and was an Associate Analyst at Rodman & Renshaw.
He has worked for firms such as Thomas Weisel Partners, KPMG, Genesis Group and Wall Street Access.
Dr. Jen received PhD in Molecular Biology from Cornell University Medical School and MBA from Rutgers University.

Yale T.
Dolginow is currently the Director at Minneapolis Heart Institute Foundation, Inc. He was formerly the Chairman, President & Chief Executive Officer at Paper Warehouse, Inc.

Phyllis R.
Yale is an Independent Director at Bristol Myers Squibb Co., where she started in 2019.
She is also an Independent Non-Executive Director at DaVita, Inc., starting in 2016.
In addition, she serves as a Director at Aledade, Inc. since 2021 and at Blue Cross & Blue Shield of Massachusetts, Inc. from 2014 to the present.
Ms. Yale is currently a Director at The Trustees of Reservations, The Bridgespan Group, Cradles To Crayons, and Montai Health, Inc. Formerly, Ms. Yale was the Chairman at Kindred Healthcare LLC from 2014 to 2018.
She also held positions as a Director at NeighborCare, Inc. from 2003 to 2005, Pediatric Services of America LLC in 2007, National Surgical Hospitals LLC from 2011 to 2016, and Carelon Behavioral Health, Inc. from 2009 to 2014.
Prior to that, she was a Partner at Bain & Co., Inc. from 1987 to 2010.
Ms. Yale completed her undergraduate studies at Harvard University and holds an MBA from Harvard Business School.

Fara Yale currently works as a Research Vice President at Gartner Research Group.

Yale Weissman was the President of Modern Optical International Ltd.

Yale Loh is currently the Chairman of Big Brothers of Greater Vancouver Foundation and a Director at UBC Investment Management Trust, Inc. He previously served as a Director at Parkit Enterprise Inc., the Association for Financial Professionals of Canada, and The Bank of Nova Scotia.
He was also the Treasurer & Vice President at Capital Power Corp.
and Capital Power Income LP.
Mr. Loh holds an MBA from Northwestern University.

Mr. Bradley Yale is a Principal at BC Partners, Inc. Prior to joining BC Partners in 2008, Mr. Yale was employed as an Analyst by Morgan Stanley.
Mr. Yale earned his BS in Operations Research and Industrial Engineering MEng in Financial Engineering from Cornell University.

Carl G.
Yale is currently a Partner at Hemric & Yale CPAs.
He previously worked as a Director at Integrity Financial Corp.
and First Gaston Bank of North Carolina.
From 2006 to 2011, he was a Director at CommunityOne Bancorp.

Janet Yale is currently the President & Chief Executive Officer at The Arthritis Society since 2012.
She is also a Director at Business for the Arts, Samara Canada, and a Member at the Information Technology Association of Canada.
In addition, she is a Member at the Ontario Bar Association and the Ottawa Centre for Research & Innovation since 1983.
Ms. Yale has previously served as the Chairman at United Way Centraide Ottawa and The National Arts Centre.
She was also the Director at The Ottawa Art Gallery and an Independent Director at MCAP Corp.
From 2003 to 2010, she held the position of Executive Vice President-Corporate Affairs at TELUS Corp.
She was a Senior Vice President at AT&T Canada Corp.
from 1992 to 1999.
Ms. Yale has also been involved with organizations such as the Canadian Film Centre, The Ottawa Hospital, Canadian Cable Television Association, and Great Canadian Theatre Co.Ms. Yale completed her undergraduate degree at McGill University in 1975.
She then pursued a graduate degree at the University of Toronto in 1976.
She later obtained another undergraduate degree from the University of Toronto in 1981.

Mr. David A.
Yale is Senior Vice President & Portfolio Manager at Nuveen Asset Management LLC.
Mr. Yale was previously employed as a Portfolio Manager by US Bancorp Asset Management, Inc. He also worked at ReliaStar Life Insurance Co. of New York, The Prudential Insurance Co. of America and U.S.
Bank.
He received his BS degree in Construction Administration from the University of Wisconsin.

David Yale is currently the Director at the National Confectioners Association of The United States, Inc. and the President & Chief Operating Officer at Just Born, Inc. He previously worked as the President & Chief Executive Officer at The Manischewitz Co.

Yale Shen is currently the Chief Technology Officer at Digital China Holdings Ltd.
He previously worked as the Chief Cloud Architect at Cisco China Co. Ltd.

Mark Edward Yale is currently a Director at Wexner Heritage Village, Arbor Walk Palms Crossing Reit LLC, Arboretum REIT LLC, Malibu Lumber Yard REIT LLC, OKC Properties REIT LLC, Kahala Venture REIT LLC, Palms Crossing II LLC, and a Member at The American Institute of Certified Public Accountants, International Council of Shopping Centers, Inc., and National Association of Real Estate Investment Trusts, Inc. He is also the Chief Financial Officer, Treasurer & Executive VP at Washington Prime Property LP, Glimcher Properties Corp., UPV Glimcher Corp., UPV Glimcher LP, and 119 Leawood LLC.
Previously, Mr. Yale worked as the Chief Financial Officer & Finance Manager at Storage USA, Inc. from 1998 to 2004.
He then served as the Chief Financial Officer, Treasurer & Executive VP at Glimcher Realty Trust from 2004 to 2015.
Prior to that, he was a Senior Manager at PricewaterhouseCoopers LLP and Coopers & Lybrand LLP from 1987 to 1998.
Mr. Yale's education includes an undergraduate degree from the University of Richmond.

Mr. Yale J.
Baron, CFA, is a Co-Chief Investment Officer & Partner at Anchorage Capital Group LLC.
Prior to joining Anchorage, Mr. Baron worked at JP Morgan and in his most recent role was responsible for the global CLO business.
Prior to joining JP Morgan, he was an investment banker in Deutsche Bank’s CDO business.
He also held various positions in investment banking including in the CDO business at Goldman Sachs.He received a B.S.
in Economics from the Wharton School at the University of Pennsylvania, where he graduated summa cum laude, and he holds the Chartered Financial Analyst designation.

Yale Podnos is currently the Chief Medical Officer & President-Practice at The Oncology Institute, Inc. He was previously the Chairman-Surgery Department at Rex Healthcare, Inc. from 2017 to 2018 and the Chief Medical Officer at West Hills Hospital & Medical Center Auxiliary from 2018 to 2019.
Dr. Podnos received his undergraduate degree from New York University, his graduate degree from Harvard T.H.
Chan School of Public Health, and his doctorate from the University of California Irvine School of Medicine.

Mr. Yale Bock, CFA MBA, is a President at YH&C Investments, Inc. He directs all operations, from investment research and portfolio management and asset allocation to trading decisions, trade execution, risk management, and client communication.
Mr. Bock earned a bachelor’s degree in economics and an MBA from UC Irvine.

Mr. Yale M.
Fergang is a Managing Partner at Royal Capital Management LLC.
Prior to co-founding the firm in 1998, Mr. Fergang was previously employed as a Research Associate at SC Fund Management LLC.
Prior to that, he was a Vice President at The Blackstone Group, Inc., and an Analyst at Goldman Sachs & Co. Mr. Fergang received his BA degree from Columbia University and an MBA from Harvard Business School.

Yale Fitz Levin is currently a Director at BlackRock Investments LLC since 2019.
Prior to this, he worked as an Investment Analyst at Farallon Capital Management LLC, a Principal at Brencourt Advisors LLC, and an Associate at Goldman Sachs & Co. LLC.
Mr. Levin holds an MBA from Harvard University, which he received in 2001, and an undergraduate degree from the US Military Academy, which he received in 1993.

Kitty Yale is currently the Chief Development Officer at Akero Therapeutics, Inc. Prior to this, she worked at Gilead Sciences, Inc. for 17 years as the Vice President-Clinical Operations.
She also worked at Roche Global Development as a Senior Clinical Research & Operations professional.
Yale received her undergraduate degree from Glasgow Caledonian University.

Yale Popowich has been a trustee at the Portland Art Museum in Oregon.

Varty Yale worked as the Chief Marketing Officer at Hostelworld Group Plc from 2019 to 2021.

David A.
Yale worked as a Manager-Fixed Income Portfolio at American Select Portfolio, Inc. from 2007 to 2013.
He also worked as a Vice President at American Strategic Income Portfolio, Inc., American Strategic Income Portfolio, Inc. II, and American Strategic Income Portfolio, Inc. III.

Yale Peebles is currently the Chief Executive Officer & Director at Blue Diamond Ventures, Inc. and also holds a position as Director at Recycled Hydro Solutions, Inc. Previously, he served as Director at Hawkeye Systems, Inc., Vice President-Strategy at Guilford Performance Textiles, Inc., Vice President-Corporate Development at Nature's Sunshine Products, Inc., and Vice President-Corporate Development & Strategy at Chromatin, Inc. Mr. Peebles completed his undergraduate degree at the US Military Academy and holds an MBA from The Wharton School of the University of Pennsylvania.

Kimberly R.
Yale is currently the Head of Investor Relations at Jersey Shore State Bank.
Previously, she worked as an Executive Assistant at Penns Woods Bancorp, Inc.

Yale Levin is currently a Director at VHS of Michigan, Inc., a Director at the Jewish Federation of Greater Hartford, and a Director & Executive Vice President at Soave Enterprises LLC since 1991.
He has previously worked as a Director at the Detroit Riverfront Conservancy, Inc., MPS Group, Inc. (Michigan), and as a Partner at PricewaterhouseCoopers LLP.
He was also the Chief Financial Officer & Executive Vice President at Highland Group Industries, Inc. Mr. Levin received his undergraduate degree from Michigan State University.

Michael Brandon Simpson worked as a Principal at Carty & Co., Inc.

John Nicol Simpson is currently an Executive Director at Marine Capital Ltd and an Independent Non-Executive Director at Awilco Drilling Plc.
He is also a Director at Paradigm Commercial Plc, Leviathan Consultancy Ltd., West Horsley Place Ltd., Friends of The River Crane Environment, Auriga Environmental LLP, Paradigm Homes Charitable Housing Association Ltd., and a Trustee at Mary Roxburghe Trust.
In the past, he served as the Chief Executive Officer at Den Norske Bank (Custody), Chairman at Sovereign Housing Capital Plc and The Sovereign Housing Group Ltd., and Director at Luminus Group Ltd., Trafalgar Shipping Ltd., Sovereign Housing Association Ltd., St. Leger Shipping Ltd., East Anglian Student Tenancies Ltd., and Environment Trust For Richmond Upon Thames.
Mr. Simpson received his undergraduate degree from The University of Southampton and his graduate degree from London Business School.

David John Simpson is the founder and CEO of Iksuda Therapeutics Ltd., which was founded in 2007.
He is currently a Non-Executive Director at Leaf Systems International Ltd.
Dr. Simpson has held former positions as a Principal Scientist at ML Laboratories Plc, Senior Scientist at Cobra Therapeutics Ltd., Head-Process Development at Allergan Biologics Ltd., Principal at Allergan Ltd.
(Ireland), and Principal at Cobra Biologics Ltd.

Joe Leigh Simpson is currently the Senior VP-Research & Global Programs at the March of Dimes Foundation since 2012.
He obtained a doctorate degree from Duke University.